摘要
目的:探讨代谢综合征孕妇血清丙氨酸氨基肽酶(AAP)、亮氨酸氨基肽酶(LAP)水平的表达,分析其临床意义。方法:选取我院2009年1月～2010年12月收治的42例代谢综合征孕妇作为研究组,入院后检测血清AAP、LAP的表达。另外选择同期我院的40例正常孕妇作为对照组,入院后检测血清AAP、LAP的表达。所有孕妇均为妊娠晚期。结果:研究组血清AAP[(64.21±9.46)U/L]、LAP[(53.53±7.67)U/L]均高于对照组血清AAP[(44.64±8.36)U/L]、LAP[(36.75±7.86)U/L],两组比较,差异有统计学意义(P<0.05)。结论:代谢综合征孕妇血清AAP、LAP明显增高,可能是机体对代谢综合征的一种保护措施。
Objective：To discuss the expression of alanine amino peptidase（APP） and leucine amino peptidase（LAP） in the serum of pregnant women with metabolic syndrome,and analyze the clinical significance.Methods：42 pregnant women with metabolic syndrome were collected from January 2009 to December 2010 in our hospital,after admission the serum AAP,LAP expression were detected.Another 40 patients with normal pregnant women were chose as control group,as the same time after admission the serum AAP,LAP expression were detected.All pregnant women were late trimester of pregnancy.Results：After the detection,the serum AAP [（64.21±9.46）U/L],LAP [（53.53±7.67）U/L] in the research group were higher than those in the control group serum AAP [（44.64±8.36）U/L],LAP[（36.75±7.86）U/L],there were significant differences in the two groups（P〈0.05）.Conclusion：Serum AAP,LAP of pregnant women with metabolic syndrome is significantly higher,which may be a protection measure for the body of the metabolic syndrome.
出处
《中国医药导报》
CAS
2011年第36期168-169,共2页
China Medical Herald
基金
2011年度广东省深圳市龙岗区医疗卫生类科技计划项目(编号:YS2011025)
